Colony Group LLC boosted its stake in UnitedHealth Group Inc (NYSE:UNH) by 4.0% during the 1st quarter, Holdings Channel reports. The firm owned 127,797 shares of the healthcare conglomerate’s stock after buying an additional 4,933 shares during the quarter. UnitedHealth Group makes up about 1.0% of Colony Group LLC’s holdings, making the stock its 16th biggest position. Colony Group LLC’s holdings in UnitedHealth Group were worth $31,870,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Capital World Investors increased its holdings in shares of UnitedHealth Group by 7.2% in the fourth quarter. Capital World Investors now owns 47,932,997 shares of the healthcare conglomerate’s stock worth $14,091,342,000 after purchasing an additional 3,219,554 shares during the last quarter. State Street Corp boosted its stake in UnitedHealth Group by 0.5% during the first quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock valued at $11,472,427,000 after buying an additional 212,240 shares during the last quarter. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 0.4% during the 1st quarter. Wellington Management Group LLP now owns 32,775,678 shares of the healthcare conglomerate’s stock valued at $8,173,598,000 after buying an additional 136,814 shares in the last quarter. Capital Research Global Investors increased its stake in UnitedHealth Group by 32.1% in the 4th quarter. Capital Research Global Investors now owns 29,851,016 shares of the healthcare conglomerate’s stock worth $8,775,602,000 after acquiring an additional 7,261,158 shares during the last quarter. Finally, Capital International Investors increased its stake in UnitedHealth Group by 4.4% in the 4th quarter. Capital International Investors now owns 25,843,701 shares of the healthcare conglomerate’s stock worth $7,597,531,000 after acquiring an additional 1,082,141 shares during the last quarter. 86.59% of the stock is owned by institutional investors and hedge funds.
Shares of UNH traded up $1.01 during trading hours on Friday, reaching $291.24. 5,172,840 shares of the company traded hands, compared to its average volume of 4,047,542. The stock’s fifty day moving average price is $293.73 and its 200 day moving average price is $281.69. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.60. The firm has a market cap of $276.21 billion, a price-to-earnings ratio of 20.38, a PEG ratio of 1.43 and a beta of 0.72. UnitedHealth Group Inc has a 12-month low of $187.72 and a 12-month high of $315.84.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, June 22nd will be issued a dividend of $1.25 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.08. This represents a $5.00 annualized dividend and a yield of 1.72%. The ex-dividend date is Friday, June 19th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 28.59%.
In related news, Director Stephen J. Hemsley sold 45,637 shares of UnitedHealth Group stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $289.11, for a total value of $13,194,113.07. Following the completion of the sale, the director now directly owns 1,013,122 shares in the company, valued at $292,903,701.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.80% of the company’s stock.
A number of research analysts recently weighed in on the stock. Raymond James cut their target price on shares of UnitedHealth Group from $340.00 to $325.00 in a report on Thursday, April 16th. Barclays reissued a “buy” rating and issued a $322.00 price objective on shares of UnitedHealth Group in a research note on Sunday, March 29th. Deutsche Bank decreased their target price on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating on the stock in a research report on Thursday, April 16th. Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a report on Friday, June 5th. They issued a “buy” rating and a $384.00 price target for the company. Finally, Stephens boosted their price objective on UnitedHealth Group from $310.00 to $325.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 2nd. Four equities research analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $323.13.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Trading Penny Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.